The global animal model market is expected to grow from a value of USD 18.43 billion in 2020 to a value of USD 30.45 billion by 2030, at an anticipated CAGR of 5.2% over the forecast period 2020-2030 including the business impact of COVID-19 on this market.
The market size of animal models was 19.59 billion dollar in 2023 and it is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030, reaching nearly 30.45 billion dollar by 2030. It is driving this growth in turn due to ongoing progress in biomedical research, new technological capabilities, and a growing need for more accurate disease modeling in drug development.
Request Sample Link To More Information: https://www.maximizemarketresearch.com/request-sample/221562/
Market Size and Future Growth Factors and Opportunities
Animal Models are essential for Biomedical Research, as they allow the scientific community to reproduce human diseases to better understand their development in a controlled environment. This pathway is important for disease mechanisms, as well as targeted therapeutics development. Moreover, growing significance of precision medicine has increased the need of genome-edited models which closely simulate human diseases, specifically opening new horizons in drug discovery and development.
Recent technological innovations, particularly the introduction of organoids and 3D models, have improved the physiologically relevance and predictivity of preclinical studies. These models are a crucial advancement in bringing us closer creating human organs as they mimic human biology more than the traditional 2D cultures scientists use every day to provide much clearer data to researchers. This increased use of these advanced models during early drug discovery is being embraced heavily within pharmaceutical companies as they understand the potential value and thus further drive the need for more acceptable animal models that utilize these technologies.
U.S. Market Direction and Investment Strategy for 2024
The U.S. remained the largest investor in biomedical research in 2024, driving impressive progress in the animal model space. It has positioned its nation as one of the best with a highly developed infrastructure and excellent healthcare facilities including excellent laboratories and specialized facilities to support their research activities and thus contributing to the growth of this market. Such investments have enabled the generation of better models for studying complex diseases and the effects of candidate therapeutics.
Segmentation of Market: Segments hold the most share
The animal model market is categorized in terms of species, application, end-user and region. The rodents segment, especially mice and rats, accounted for the largest share of the market. Mice are used in many areas of biomedical research because they are genetically similar to humans, but also easy to handle and inexpensive to breed and maintain. By application, oncology segment holds the large share of the market, which is primarily attributed to the widespread usage of animal models in cancer studies to understand the biology of tumors and to assess treatment approaches.
What are the leading companies in the competitive landscape
Animal model market is a fragmented market with the presence of number of key players contributing significantly in the dynamics of the global animal model market. The top in the five largest market share companies are:
Charles River Laboratories International, Inc.: One of the premier providers of animal models and preclinical services, Charles River Laboratories has incorporated advanced imaging technologies into its offerings which will provide researchers with dynamic insights for preclinical studies.
The Jackson Laboratory: Famous for its massive collection of genetically defined mice, The Jackson Laboratory has been continuously on-date with the development of innovative mice models, serving as a fine platform for multiple research topics such as oncology and neurobiology.
Taconic Biosciences, Inc.: Taconic Biosciences has built a unique business specialized in genetically engineered rodent models, now providing custom model generation and breeding for the biomedical research community.
Envigo: A wide range of research models and other related services with a focus on implementing health standards for improving the health and genetic quality of Envigo's animal models for reliable and reproducible research.
Harlan Laboratories, Inc. → Is one of the largest providers of research models and more than ever, Harlan is consistently working to improve ethical husbandry practices to better animal welfare, as it also pertains to biomedical research.
Want to access more insights? The journey starts from requesting Sample :https://www.maximizemarketresearch.com/request-sample/221562/
Regional Analysis
An animal model market in North America can capture the largest share due to increased investment in biomedical research and advanced research infrastructure. US and Canada have invested heavily in biomedical research, catalyzing developments in different areas of the sciences, thereby further increasing the demand for animal models and services associated.
Asia pacific is well poised to capture the share of animal model market in the following years, (China, Japan & South Korea) are devoting increasing amount of money to biomedical research, which fuels the growth of the market. Beijing, Shanghai, and Tokyo are forging big-bang biomedical research centers, drawing scientists from around the world and propelling demand for animal models. All such factors have further driven the use of animal models for preclinical testing of drug candidates for safety and efficacy due to increasing drug development activities in emerging markets of China and India, where much of the pharmaceutical industrial growth has been seen in the last decade.
Research report Summary: — Maximize Market Research Report : https://www.maximizemarketresearch.com/market-report/animal-model-market/221562/
Conclusion
The global animal model market is expected to grow significantly over the next few years due to advancements in biomedical research, technology, and the rising focus on precision medicine. Stakeholders should focus on the following to capitalize on emerging opportunities:
Technological Investments: Inclusion of technologies, including organoids and 3D models that increase preclinical physiological comparability and relevance.
Broadening Collaborations: Establishing alliances between scientific institutions, industry, and CROs to facilitate faster development of innovative therapies.
Compliance with Ethical Principles: The principles of Replacement, Reduction, and Refinement (3Rs) are necessary for the humane use of animal models, guiding whether and how animals are used or appropriately utilized in research.
Related Reports :
Wearable Pregnancy Devices Market https://www.maximizemarketresearch.com/market-report/global-wearable-pregnancy-devices-market/84933/
global Bioremediation Technology https://www.maximizemarketresearch.com/market-report/global-bioremediation-technology-services-market/72113/
global Mobile health market https://www.maximizemarketresearch.com/market-report/mhealth-market/606/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 9607365656
